F. Tas Et Al. , "Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients," BIOMEDICAL REPORTS , vol.4, no.4, pp.489-492, 2016
Tas, F. Et Al. 2016. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients. BIOMEDICAL REPORTS , vol.4, no.4 , 489-492.
Tas, F., Karabulut, S., Tastekin, D., & Duranyildiz, D., (2016). Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients. BIOMEDICAL REPORTS , vol.4, no.4, 489-492.
Tas, Faruk Et Al. "Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients," BIOMEDICAL REPORTS , vol.4, no.4, 489-492, 2016
Tas, Faruk Et Al. "Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients." BIOMEDICAL REPORTS , vol.4, no.4, pp.489-492, 2016
Tas, F. Et Al. (2016) . "Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients." BIOMEDICAL REPORTS , vol.4, no.4, pp.489-492.
@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients}, journal={BIOMEDICAL REPORTS}, year=2016, pages={489-492} }